References
- Cheng V, Ho P, Lee R, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803–809. doi:10.1007/s10096-002-0821-212461590
- Bhattacharya A, Mukherjee S. Paradoxical reaction in the form of pleural effusion after onset of anti-tuberculous medication for tubercular lymphadenitis. Clin Med. 2017;17:143–145. doi:10.7861/clinmedicine.17-2-143
- Shinohara T, Kagawa K, Okano Y, et al. Disseminated tuberculosis after pregnancy progressed to paradoxical response to the treatment: report of two cases. BMC Infect Dis. 2016;16:284. doi:10.1186/s12879-016-1624-x27297079
- Okazaki A, Watanabe S, Yoneda T, et al. Paradoxical reaction to antituberculosis therapy after 6 months of treatment for pulmonary tuberculosis: a case report. J Infect Chemother. 2016;22:748–751. doi:10.1016/j.jiac.2016.03.01227282293
- VCC C. Paradoxical response during anti-tuberculosis therapy. Hong Kong Med J. 2006;11:20–21.
- Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2007;11:1290–1295.18034948
- Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40:1368–1371. doi:10.1086/42931715825042
- Wendel KA, Alwood KS, Gachuhi R, et al. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest. 2001;120:193–197. doi:10.1378/chest.120.1.19311451837
- NARITA M, ASHKIN D, HOLLENDER ES, PITCHENIK AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157–161. doi:10.1164/ajrccm.158.1.97120019655723
- Lanzafame M, Vento S. Tuberculosis-immune reconstitution inflammatory syndrome. J Clin Tuberc Other Mycobact Dis. 2016;3:6–9. doi:10.1016/j.jctube.2016.03.00231723680
- Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516–523. doi:10.1016/S1473-3099(08)70184-118652998
- Breen RAM, Smith CJ, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59:704–707. doi:10.1002/cncr.2561615282393
- Singh U, Mohan V, Ramaraj M. Areekkara P, Deshawar S. Varied presentations of paradoxical upgrading reactions in pulmonary tuberculosis. Medicine. 2016;5.
- Geri G, Passeron A, Heym B, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013;41:537–543. doi:10.1007/s15010-012-0376-923203899
- Al-Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med. 1996;90:211–214. doi:10.1016/S0954-6111(96)90289-98736654
- Choi YW, Jeon SC, Seo HS, et al. Tuberculous pleural effusion: new pulmonary lesions during treatment. Radiology. 2002;224:493–502. doi:10.1148/radiol.224201128012147848
- Akira M, Sakatani M, Ishikawa H. Transient radiographic progression during initial treatment of pulmonary tuberculosis: CT findings. J Comput Assist Tomogr. 2000;24:426–431. doi:10.1097/00004728-200005000-0001410864081
- Ren X. Liu W and Liu Y. Effects of fluconazole on the clinical outcome and immune response in fungal co-infected tuberculosis patients. Microb Pathogen. 2018;117:148–152. doi:10.1016/j.micpath.2018.02.01529432913
- Guimarães MD, Marchiori E, de Souza Portes Meirelles G, et al. Fungal infection mimicking pulmonary malignancy: clinical and radiological characteristics. Lung. 2013;191:655–662. doi:10.1007/s00408-013-9506-024043490
- Bhatt MLB, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J Cancer. 2012;1:36–42. doi:10.4103/2278-330X.9650724455507
- Wu C-Y, Hu H-Y, Pu C-Y, et al. Pulmonary tuberculosis increases the risk of lung cancer. Cancer. 2011;117:618–624.20886634
- Kovács A, Baksay B, Cserenyecz A, et al. Occurrence of pulmonary rheumatoid nodules following biological therapies. Clin Rheumatol. 2015;34:1639–1642. doi:10.1007/s10067-014-2789-625267563
- Brown CS, Smith CJ, Breen RAM, et al. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis. 2016;16:479. doi:10.1186/s12879-016-1816-427600661
- Cheng VCC, Yam WC, Woo PCY, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003;22:597–602. doi:10.1007/s10096-003-0998-z14508660
- Sun H-Y, Munoz P, Torre-Cisneros J, et al. Mycobacterium tuberculosis—associated immune reconstitution syndrome in solid-organ transplant recipients. Transplantation. 2013;95:1173–1181. doi:10.1097/TP.0b013e31828719c823435454
- Desch AN, Gibbings SL, Goyal R, et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med. 2015;193:614–626. doi:10.1164/rccm.201507-1376OC
- Xie YL, Rosen LB, Sereti I, et al. Severe paradoxical reaction during treatment of disseminated tuberculosis in a patient with neutralizing anti-IFNγ autoantibodies. Clin Infect Dis. 2016;62:770–773. doi:10.1093/cid/civ99526646678
- Barr D, Coussens A, Irvine S, et al. Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy. Int J Tuberc Lung Dis. 2017;21:677–683. doi:10.5588/ijtld.16.092728482963